Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Modulation of Rhamm (CD168) for selective adipose tissue development

Patent ·
OSTI ID:1130537
Herein is described the methods and compositions for modulation of Rhamm, also known as CD 186, and its effects on wound repair, muscle differentiation, bone density and adipogeneisis through its ability to regulate mesenchymal stem cell differentiation. Compositions and methods are provided for blocking Rhamm function for selectively increasing subcutaneous, but not, visceral fat. Compositions and methods for modulating Rhamm in wound repair are also described.
Research Organization:
LBNL (Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States))
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-05CH11231
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Number(s):
8,715,653
Application Number:
12/515,405
OSTI ID:
1130537
Country of Publication:
United States
Language:
English

References (34)

Signaling Properties of Hyaluronan Receptors journal February 2002
Mesenchymal Bone Marrow Stem Cells More Effectively Stimulate Regeneration of Deep Burn Wounds than Embryonic Fibroblasts journal January 2003
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility journal June 1992
The influence of the microenvironment on the malignant phenotype journal August 2000
Hyaluronan receptor expression increases in fetal excisional skin wounds and correlates with fibroplasia journal July 1998
Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury: Enhancing wound healing with stem cells journal May 2006
Fibroblasts require protein kinase C activation to respond to hyaluronan with increased locomotion journal June 2001
Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. journal March 1995
The Hyaluronan Receptor RHAMM Regulates Extracellular-regulated Kinase journal May 1998
RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy journal December 2004
MAP kinases and cell migration journal September 2004
Chronic liver injury, TGF-β, and cancer journal December 2001
Hyaluronan and Homeostasis: A Balancing Act journal February 2002
Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis journal October 2003
Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages journal August 2006
Purification of a hyaluronate-binding protein fraction that modifies cell social behavior journal October 1982
 -Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds journal April 2002
Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation journal July 1995
CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity journal September 1997
RHAMM/CD168-R3 Peptide Vaccination of HLA-A2+ Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Multiple Myeloma (MM). journal November 2005
Anti-tnfα therapy is useful in rheumatoid arthritis and crohn’s disease: analysis of the mechanism of action predicts utility in other diseases journal December 1998
Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. journal April 1997
Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor) journal October 2003
Of Mice and Not Men: Differences between Mouse and Human Immunology journal February 2004
Hyaluronan and Hyaluronan Synthases: Potential Therapeutic Targets in Cancer journal February 2005
Stretch-induced bladder smooth muscle cell (SMC) proliferation is mediated by RHAMM-dependent extracellular-regulated kinase (erk) signaling journal June 2001
Unconventional Secretory Routes: Direct Protein Export Across the Plasma Membrane of Mammalian Cells journal August 2005
Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors journal February 1999
Rhamm−/− fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair journal December 2006
PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair journal January 2004
Bloodstream Cells Phenotypically Identical to Human Mesenchymal Bone Marrow Stem Cells Circulate in Large Amounts Under the Influence of Acute Large Skin Damage: New Evidence for Their Use in Regenerative Medicine journal April 2006
TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. journal November 1993
The future of wound healing: Pursuing surgical models in transgenic and knockout mice journal October 2004
Hyaluronan: from extracellular glue to pericellular cue journal July 2004

Similar Records

Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells
Journal Article · Wed Oct 14 20:00:00 EDT 2015 · Frontiers in Cell and Developmental Biology · OSTI ID:1629220

Site-specific differences of insulin action in adipose tissue derived from normal prepubertal children
Journal Article · Mon Aug 15 00:00:00 EDT 2005 · Experimental Cell Research · OSTI ID:20717647

Translin modulates mesenchymal cell proliferation and differentiation in mice
Journal Article · Sat Sep 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23103538

Related Subjects